Milan, Italy, and New York, NY—Indena has entered into a specific development program with Onegevity, a health intelligence platform for personalized wellness, according to a press release.
Onegevity uses artificial intelligence and machine learning to map, integrate, and understand the dynamic biological features that describe a person’s health, the press release explains. The platform distills data regarding a person’s microbiome, genetics, and blood biomarkers into actionable information. Onegevity also uses pattern recognition, neural networks, and trillions of data points collected on other individuals to help the user optimize their health through diet, nutrition, and lifestyle measures.
Related: #NaturallyInformed: People and Planet
Nature’s Bounty Launches Personalized Nutrition Tool
Transparency Top 2021 Trend, According to Innova Market Insights
“We are proud to cooperate with Onegevity, which represents an absolute innovation for consumers’ health,” said Daniele Giavini, Managing Director at Indena, in the press release. “Our project with Onegevity is perfectly in line with Indena’s approach and with our continuous focus on research and development of highly effective solutions that are synergistic to the Onegevity wellness plan. The collaboration will allow us to process certain botanical ingredients out of Indena’s portfolio through the Onegevity AI platform, with the aim of discovering novel potential indications, and beneficial effects for new or known botanical ingredients, as applicable to the pharmaceutical or nutraceutical market. This project fits very well to our credo ‘Science is our Nature.’”
Paul Jacobson, CEO of Onegevity and Thorne, added: “One of our partnership goals is to identify effective strategies to reduce the biological age versus the chronological age of individuals by offering actionable solutions. We’ve had a long history working with Indena and have found them to be the premier partner for developing plant-based health products and a strong commitment to research. We expect to gain many insights from this compound screening cooperation project to improve personalized solutions for people worldwide.”